ARCHIVE run · 78e2f35e4569

```json ["healthcare markets", "health tech investment", "digital health policy", "healthcare technology", "healthcare business", "hospital executives", "insurance executives", "healthcare investors", "healthcare entrepreneurship", "healthcare policy", "medical technology", "healthcare analytics"] ```

This article contains no substantive analytical content — it is purely a promotional/administrative announcement from a Substack newsletter called "Thoughts on Healthcare Markets & Technology." The central communication is that the publication has launched a podcast on Spotify, that articles are converted into podcast episodes, and that paid subscribers receive access to a private podcast feed com

[]

```json [ { "claim_text": "REDMOD's true competitive moat is its longitudinal paired imaging-outcomes dataset linked to cancer registry and death index, not the radiomics architecture itself, which relies on decades-old feature extraction mathematics.", "claim_type": "mechanism_explanation" }, { "claim_text": "At average-risk prevalence (20–40 PDAC cases per 100,000 person-years)

```json [] ``` The article content does not exist (page not found error). No claims can be extracted from non-existent text. Generating fabricated claims would violate the requirement that claims be "specific to this article's unique findings or arguments." Creating claims based on the title alone would be speculation, not extraction. To complete this task, the actual article content must be acc

```json [] ```

```json [] ``` The article contains no extractable claims meeting your criteria. As the summary explicitly states, this is a purely administrative notice with no substantive analytical content, arguments, data, findings, or policy positions. The only "claims" present are logistical statements (e.g., "I am pausing billing") that are: - Personal/administrative rather than arguable - Not specific

```json [] ``` The article contains no extractable claims meeting your criteria. The article is purely promotional with no assertions about facts, policies, mechanisms, or arguments that could be agreed or disagreed with. It makes no claims about healthcare markets, technology, or any other substantive topic—only announces a discount offer. Therefore, no valid claims exist to extract.

```json [] ``` **Explanation**: No claims can be extracted because the article content is not available. The source returned a 404 error with no text, argument, findings, or data. Fabricating claims would violate the requirement that claims be "specific to this article's unique findings or arguments." A valid response requires the actual article content to be retrieved and resubmitted.

The generative-versus-discriminative line is where this gets interesting. RosettaSearch is still optimizing within a backbone-conditioned space, which means the search is fundamentally constrained by the structural scaffold you give it. That's a more powerful discriminator, not a different search space. And the question I keep coming back to after looking at what Profluent is doing with ProGen3 i

The "regulatory capture" framing here is doing a lot of work it hasn't earned, because the FDA removing semaglutide and tirzepatide from shortage lists after supply normalized is actually the standard process working as designed, not a manufacturer favor. But the more interesting tension is the one getting skipped entirely. The compounding crackdown and the BALANCE Model's $245 CMS-negotiated net

The diagnostic accuracy headline is real but it's also the slowest path to actual clinical impact. The 67% vs 55% gap matters a lot less in the near term than what's already happening at scale without any FDA review or hospital IT committee sign-off. OpenAI's own usage data shows 40M+ people a day using ChatGPT for health conversations, with 70% of those conversations happening outside clinic hou

The knowledge graph framing is interesting but it points at a tension I don't see discussed much: graphs encode known biology, which means they compress well but they also hard-ceiling you at what evolution already explored. Profluent's bet, and the reason the Lilly structure caught my attention, is that generative protein models don't just predict responses to known perturbations. They write seq